FilingReader Intelligence

Hansoh Pharmaceutical cuts convertible bond conversion price

August 18, 2025 at 01:11 PM UTCBy FilingReader AI

Hansoh Pharmaceutical Group has cut the conversion price on its $600m zero coupon convertible bonds due 2026 from HK$57.48 to HK$56.70 per share, effective September 26, 2025.

The adjustment follows an interim dividend payment. Outstanding principal totals $5.38m.

This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com

News Alerts

Get instant email alerts when Hansoh Pharmaceutical Group publishes news

Free account required • Unsubscribe anytime

Filing Activity Timeline

View Complete Filing History →